MacAfee LK - Search Results

1

Reasons for past abortions among women in treatment for opioid use disorder.

Harfmann RF, Heil SH, Cannon LM, Dalton VK, Kusunoki Y, Kock LS, MacAfee LK. Harfmann RF, et al. Among authors: macafee lk. Psychol Addict Behav. 2024 Mar;38(2):193-196. doi: 10.1037/adb0000959. Epub 2023 Sep 14. Psychol Addict Behav. 2024. PMID: 37707466

2

Stigma and Reproductive Health Service Access Among Women in Treatment for Substance Use Disorder.

McCartin M, Cannon LM, Harfmann RF, Dalton VK, MacAfee LK, Kusunoki Y. McCartin M, et al. Among authors: macafee lk. Womens Health Issues. 2022 Nov-Dec;32(6):595-601. doi: 10.1016/j.whi.2022.06.003. Epub 2022 Jul 9. Womens Health Issues. 2022. PMID: 35821183

3

Substance Use Treatment Patient and Provider Perspectives on Accessing Sexual and Reproductive Health Services: Barriers, Facilitators, and the Need for Integration of Care.

MacAfee LK, Harfmann RF, Cannon LM, Minadeo L, Kolenic G, Kusunoki Y, Dalton VK. MacAfee LK, et al. Subst Use Misuse. 2020;55(1):95-107. doi: 10.1080/10826084.2019.1656255. Epub 2019 Aug 27. Subst Use Misuse. 2020. PMID: 31455128

4

Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan.

MacAfee LK, Harfmann RF, Cannon LM, Kolenic G, Kusunoki Y, Terplan M, Dalton VK. MacAfee LK, et al. Obstet Gynecol. 2020 Feb;135(2):361-369. doi: 10.1097/AOG.0000000000003666. Obstet Gynecol. 2020. PMID: 31923070

5

Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.

Rey CN, Badger GJ, Melbostad HS, Wachtel D, Sigmon SC, MacAfee LK, Dougherty AK, Heil SH. Rey CN, et al. Among authors: macafee lk. Contraception. 2020 May;101(5):333-337. doi: 10.1016/j.contraception.2020.01.010. Epub 2020 Feb 1. Contraception. 2020. PMID: 32014521 Free PMC article.

6

Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care.

Melbostad HS, Badger GJ, Rey CN, MacAfee LK, Dougherty AK, Sigmon SC, Heil SH. Melbostad HS, et al. Among authors: macafee lk. Subst Use Misuse. 2020;55(14):2403-2408. doi: 10.1080/10826084.2020.1823418. Epub 2020 Oct 5. Subst Use Misuse. 2020. PMID: 33019893 Free PMC article.

7

Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs.

MacAfee LK, Dalton V, Terplan M. MacAfee LK, et al. J Addict Med. 2019 May/Jun;13(3):177-181. doi: 10.1097/ADM.0000000000000471. J Addict Med. 2019. PMID: 30394994

8

Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial.

Heil SH, Melbostad HS, Matusiewicz AK, Rey CN, Badger GJ, Shepard DS, Sigmon SC, MacAfee LK, Higgins ST. Heil SH, et al. Among authors: macafee lk. JAMA Psychiatry. 2021 Oct 1;78(10):1071-1078. doi: 10.1001/jamapsychiatry.2021.1715. JAMA Psychiatry. 2021. PMID: 34259798 Free PMC article. Clinical Trial.

9

Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.

Melbostad HS, Wachtel DS, Lipke KA, Badger GJ, Matusiewicz AK, Rey CN, MacAfee LK, Dougherty AK, Heil SH. Melbostad HS, et al. Among authors: macafee lk. Contraception. 2022 Jun;110:16-20. doi: 10.1016/j.contraception.2022.02.013. Epub 2022 Mar 11. Contraception. 2022. PMID: 35283082 Free PMC article. Clinical Trial.

10

Prior uterine evacuation and risk for preterm birth.

MacAfee LK, Dalton VK. MacAfee LK, et al. Am J Obstet Gynecol. 2016 Dec;215(6):806. doi: 10.1016/j.ajog.2016.07.021. Epub 2016 Jul 17. Am J Obstet Gynecol. 2016. PMID: 27435054 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page